NanoNail™ Platform Development
Oncology (Broad Solid Tumors)
Key Facts
About Kibur Medical
Kibur Medical is a private, pre-revenue biotech company developing a novel implantable microdevice platform for in vivo cancer drug testing. Its core technology, the NanoNail™, is implanted into tumors to release microdoses of multiple therapeutics, and upon retrieval, the surrounding tissue is analyzed using multi-omic profiling and machine learning to generate a comprehensive molecular map of drug response. This platform is designed to de-risk oncology drug development by providing unprecedented, physiologically relevant data on drug efficacy and mechanism of action earlier in the pipeline. Kibur has validated its approach through multiple peer-reviewed publications and a partnership with Charles River Laboratories, positioning it as a tool for both pharmaceutical developers and clinical researchers.
View full company profile